StockData
Zura Bio Ltd logo

Zura Bio Ltd (ZURA) stock

ZURANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 5/30
$0.93−0.02 (-2.30%)

Close on Nov 20, 2026Market cap $89.63MP/E –Yield –

Zura Bio price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Zura Bio's price to book ratio was 3.7× on Apr 30, 2026, against 0.7× a year earlier. Over the last 3 years it ranged from 0.5× to 8.0×, with a median of 2.5×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Apr 30, 20263.7×+0.5
2025Dec 31, 20253.1×+2.1
2024Dec 31, 20241.1×−2.1
2023Dec 29, 20233.2×–

More Zura Bio figures

See a number that looks wrong?